Multiple Myeloma with Suspected Non-Secretory Type

Annisa Ginar Indrarsi, Usi Sukorini


Multiple Myeloma (MM) is a hematological malignancy characterized by clonal plasma cell in bone marrow that produce
abnormal globulin, which resulted in monoclonal gammopathy. Multiple Myeloma Non-Secretory (MMNS) is a very rare
form of multiple myeloma with monoclonal plasmocytic proliferation in bone marrow supported by clinical manifestation
and radiological findings. However, plasma cells fail to secrete immunoglobulin. A 44-year-old female came to Sardjito
General Hospital with main complaints of weakness and back pain. General weakness and pale palpebral conjunctiva were
6 observed (+/+), liver and spleen were not palpable. Blood test results were as follows: Hb 3.0 g/dL, RBC 1.07 x 10 / μL, WBC
3 3 562 x 10 /μL, PLT 114 x 10 /μL, A/G ratio 1.07, BUN 51.5 mg/dL, creatinine 4.62 mg/dL, and calcium 3.1 mmol/L. Skeletal
survey suggested a multiple osteolytic. Protein electrophoresis revealed hypogammaglobulinemia with no M-spike. There
were 66% of plasma cells in bone marrow. Patient was diagnosed by MMNS. Diagnosis MMNS can be established if clonal
plasmacytes is accompanied with renal insufficiency and hypercalcemia. However, monoclonal gammopathy was not found
in serum protein electrophoresis. A case reported of 44-year-old female diagnosed as MMNS with 'punched out' multiple
osteolytic, increased plasma cells in bone marrow without evidence of paraprotein in circulation proved by low A/G ratio and
negative M-spike.


Multiple myeloma non-secretory, hypogammaglobulinemia

Full Text:



Lonial BS, Kaufman JL. Non-secretory myeloma: A

clinician ' s guide Review, 2019; 4-7.

Wei A. Bone marrow immunohistology of plasma cell

neoplasms. J Clin Pathol, 2003; 56(6): 406-11.

Aman AK. Profil penderita multiple myeloma di bagian

Patologi Klinik FK USU/RSUP H. Adam Malik Medan.

Maj Kedokt Nusant. 2005; 38(2): 176-9.

Ludwig H, Bolejack V, Crowley J, Bladé J, San Miguel J,

et al. Survival and years of life lost in different age

cohorts of patients with multiple myeloma. J Clin

Oncol, 2010; 28(9): 1599-605.

Whicher JT, Davies JD, Grayburn JA. Intact and

fragmented intracellular immunoglobulin in a case

of non secretory myeloma. J Clin Pathol, 1975; 28(1):


Middela S, Prakash K. Non-secretory multiple

myeloma. Arch Pathol Lab Med, 2009; 43(4): 408-11.

Palumbo A, Anderson K. From multiple myeloma. N

Engl J Med, 2010; 1-11.

Sharma A, Kaushal M, Chaturvedi NK, Yadav R.

Cytodiagnosis of multiple myeloma presenting as

orbital involvement: A case report. Cyto Journal,

; 3: 1-5.

Prasad R, Yadav RR, Singh A, Mathur SP, Mangal Y,

Singh M. Non-secretory multiple myeloma presenting

with diffuse sclerosis of affected bones interspersed

with osteolytic lesions. Br J Radiol, 2009; 82(974):


C a l d a s . N o n - s e c r e t o r y m y e l o m a o r l i g h t

chain-producing multiple myeloma: A case report.

J Med Cases, 2011; 2(3): 97-100.

Kyle RA, Rajkumar S V. Criteria for diagnosis, staging,

risk stratification and response assessment of multiple

myeloma. Leukemia, 2009; 23(1): 3-9.

Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J,

Merlini G, et al. International myeloma working group

updated criteria for the diagnosis of multiple

myeloma. Lancet Oncol [Internet]. 2014;15(12):

e538-48. Available from:

S1470-2045(14)70442-5 (accessed 7 October, 2019).

Dupuis MM, Tuchman SA. Non-secretory multiple

myeloma: From biology to clinical management. Onco

Targets Ther, 2016; 9: 7583-90.

Corso A, Mangiacavalli S. Review articles

non-secretory myeloma: Ready for a new definition?.

Mediterr J Hematol Infect Dis [Internet]. 2017; 9(Mc):

Available from: (accessed 24

June, 2019).

Maimun Zulhaidah Arthamin, Nyi R. Wahidah BAS.

Myeloma multiple non-secretory. Clin Pathol and Med

Lab, 2012; 22(1): 99-103.



  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.